By Dave Sebastian

 

CVS Health Corp. said its second-quarter profit rose as its insurance arm benefited from deferred elective procedures amid the Covid-19 shelter-in-place measures, though it also had lower new therapy prescriptions.

The pharmacy chain, which also owns insurance giant Aetna, on Wednesday posted a net profit of $2.98 billion, or $2.26 a share, compared with $1.94 billion, or $1.49 a share, in the same period last year.

Adjusted earnings were $2.64 a share. Analysts polled by FactSet were looking for adjusted earnings of $1.91 a share.

The Woonsocket, R.I.-based company reported sales of $65.34 billion, up from $63.43 billion in the year-ago period. Analysts polled by FactSet were expecting $64 billion.

Sales in the company's health-care benefits segment, which includes Aetna, rose 6.1% to $18.47 billion. It reported a medical-loss ratio, or the share of premiums the insurer pays out in claims, of 70.3%.

Sales in its pharmacy-services segment rose slightly to $34.89 billion, partially offset by lower provider visits during the quarter. Its retail segment sales rose 1% to $21.66 billion, though prescriptions filled declined 1.1% on a 30-day equivalent basis.

 

Write to Dave Sebastian at dave.sebastian@wsj.com

 

(END) Dow Jones Newswires

August 05, 2020 07:06 ET (11:06 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more CVS Health Charts.